Journal
International Journal of Radiation Oncology*Biology*Physics
Publication Date
11-15-2023
Volume
117
Issue
4
First Page
799
Last Page
808
Document Type
Open Access Publication
DOI
10.1016/j.ijrobp.2023.05.023
Rights and Permissions
Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):799-808. doi: 10.1016/j.ijrobp.2023.05.023. Copyright 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Parikh, Parag Jitendra; Kim, Hyun; Henke, Lauren E; Price, Alex T; and et al., "A multi-institutional phase 2 trial of ablative 5-fraction stereotactic magnetic resonance-guided on-table adaptive radiation therapy for borderline resectable and locally advanced pancreatic cancer." International Journal of Radiation Oncology*Biology*Physics. 117, 4. 799 - 808. (2023).
https://digitalcommons.wustl.edu/oa_4/2630